Can a simple checklist forecast PTSD after critical illness?

NCT ID NCT07747415

First seen Aug 05, 2026 · Last updated Aug 06, 2026 · Updated 1 time

Summary

This study asks whether routine medical data can predict which survivors of an emergency intensive care unit (EICU) stay will develop post-traumatic stress disorder (PTSD) one month after leaving the hospital. Researchers will follow about 800 adult patients, collecting details from their emergency department and ICU care—like vital signs, treatments, and severity of illness—and then assess them for PTSD using a standard diagnostic interview. The goal is to build a risk prediction model that helps doctors identify high-risk patients early and offer timely psychological support. No experimental treatments are involved; the study only observes and analyzes existing clinical information.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could give doctors a simple tool to spot EICU survivors at high risk of PTSD, enabling early psychological support and follow-up care.
What could go wrong
This is an observational study, not a treatment trial. The model may not be accurate enough for all patients, and PTSD risk depends on many personal factors not fully captured by clinical data.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POST TRAUMATIC STRESS DISORDER (PTSD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Sir Run Run Shaw Hospital, Zhejiang University School of Medicine

    Hangzhou, Zhejiang, 310016, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.